Clinical Trial Update: A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps [Phase 2]

View source ↗

Summary

This update reports the completion of an extension Phase 2 clinical trial evaluating TQC2731 injection for chronic rhinosinusitis with nasal polyps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• TQC2731 injection (TQC2731)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: COMPLETED